Supernus, Inc. (INDV) stock
INDVNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SUPN
$35.37+0.12 (+0.34%)
Close on Oct 30, 2026Market cap $4.17BP/E 9.9Yield –
Supernus gross margin
Gross margin is gross profit as a percentage of revenue.
Supernus's gross margin for the twelve months ending Sep 30, 2026 was 85.0%. For fiscal 2025 it was 80.2%, against 80.6% the year before. The highest annual figure on record is 84.1% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 80.2% | −0.3 |
| FY2024 | Dec 31, 2024 | 80.6% | −3.5 |
| FY2023 | Dec 31, 2023 | 84.1% | +1.0 |
| FY2022 | Dec 31, 2022 | 83.1% | −0.8 |
| FY2021 | Dec 31, 2021 | 83.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 85.7% | +12.4 |
| Q2 FY2026 | Jun 30, 2026 | 85.7% | +2.9 |
| Q1 FY2026 | Mar 31, 2026 | 87.4% | +4.3 |
| Q4 FY2025 | Dec 31, 2025 | 81.6% | −2.0 |
| Q3 FY2025 | Sep 30, 2025 | 73.2% | −5.3 |
| Q2 FY2025 | Jun 30, 2025 | 82.8% | +9.2 |
| Q1 FY2025 | Mar 31, 2025 | 83.1% | −3.5 |
| Q4 FY2024 | Dec 31, 2024 | 83.6% | – |
| Q3 FY2024 | Sep 30, 2024 | 78.5% | – |
| Q2 FY2024 | Jun 30, 2024 | 73.6% | – |
| Q1 FY2024 | Mar 31, 2024 | 86.6% | – |
See a number that looks wrong?